Haoxi Health Technology Limited
HAO
$1.25
$0.03983.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -130.60% | -130.60% | 1.64% | 1.64% | 70.07% |
| Total Depreciation and Amortization | -17.24% | -17.24% | -115.15% | -115.15% | 544.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -330.63% | -330.63% | 1.72% | 1.72% | -93.11% |
| Cash from Operations | -847.64% | -847.64% | 2.66% | 2.66% | 46.83% |
| Capital Expenditure | 67.90% | 67.90% | 6.22% | 6.22% | -350.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -18,880.25% | -18,880.25% | -7,346.89% | -7,346.89% | -350.00% |
| Total Debt Issued | 147.25% | 147.25% | -66.59% | -66.59% | -5.30% |
| Total Debt Repaid | -777.84% | -777.84% | 86.97% | 86.97% | 21.05% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 106.63% | 106.63% | 93.38% |
| Cash from Financing | 3,135.67% | 3,135.67% | 6,037.39% | 6,037.39% | -87.76% |
| Foreign Exchange rate Adjustments | 103.22% | 103.22% | 2,180.88% | 2,180.88% | -23,546.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,793.82% | 2,793.82% | 545.31% | 545.31% | -104.21% |